Pharmaron Beijing Co., Ltd. (SHE:300759)

China · Delayed Price · Currency is CNY

27.11

-0.24 (-0.88%)

At close: Mar 9, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services)	7.05B	6.66B	-	4.57B	3.24B
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services) Growth	5.81%	-	-	41.09%	-
Chemical and formulation process development and manufacturing services	2.99B	2.71B	2.41B	1.75B	1.22B
Chemical and formulation process development and manufacturing services Growth	10.24%	12.64%	37.83%	42.90%	35.54%
Clinical Research Services	1.83B	1.74B	1.39B	956.36M	629.35M
Clinical Research Services Growth	5.12%	24.66%	45.72%	51.96%	37.94%
Macromolecule and Cell and Gene Therapy Services	407.52M	424.94M	351.03M	150.97M	26.65M
Macromolecule and Cell and Gene Therapy Services Growth	-4.10%	21.06%	132.52%	466.58%	-
Others	6.40M	4.61M	26.19M	24.48M	19.55M
Others Growth	38.79%	-82.39%	6.99%	25.21%	-1.33%
Laboratory Services	-	-	6.09B	-	-
Total	12.28B	11.54B	10.27B	7.44B	5.13B
Total Growth	6.39%	12.39%	37.92%	45.00%	36.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Europe	2.27B	1.84B	1.48B	1.16B	979.76M
Europe Growth	23.18%	24.35%	27.52%	18.71%	-
North America	7.85B	7.40B	6.64B	4.78B	3.27B
North America Growth	6.11%	11.39%	39.03%	46.08%	-
Others	39.51M	48.87M	25.01M	33.96M	39.31M
Others Growth	-19.17%	95.40%	-26.34%	-13.61%	-
Mainland China	1.85B	1.97B	1.88B	1.27B	700.22M
Mainland China Growth	-6.46%	5.02%	47.50%	82.08%	-
Asia (Excluding Chinese Mainland)	264.27M	269.04M	233.48M	192.87M	142.92M
Asia (Excluding Chinese Mainland) Growth	-1.77%	15.23%	21.05%	34.95%	-
Total	12.28B	11.54B	10.27B	7.44B	5.13B
Total Growth	6.39%	12.39%	37.92%	45.00%	36.64%

Source: S&P Global Market Intelligence.